Help Pharmacy Best Alternatives for Each Use Case

At a glance
- Pharmacy type / 503B outsourcing facility (FDA-registered, Houston TX)
- Primary products / compounded semaglutide, tirzepatide, BPC-157, testosterone, estradiol
- Prescription required / yes, via partnered prescribers or your own provider
- Typical GLP-1 cost / $150, $350/month depending on dose and formulation
- FDA oversight level / 503B facilities follow stricter standards than 503A pharmacies
- Key limitation / does not provide in-house physician consultations directly to patients
- Best alternatives by use case / Hallandale Health (HRT), Tailor Made Health (peptides), Ro Body (GLP-1 telehealth), Defy Medical (TRT)
- GLP-1 trial reference / STEP-1 (N=1,961) showed 14.9% mean body weight reduction with semaglutide 2.4 mg at 68 weeks
- FDA shortage status / FDA declared semaglutide shortage resolved March 2024; tirzepatide shortage resolved in late 2024
What Is Help Pharmacy and Is It Legitimate?
Help Pharmacy is a Food and Drug Administration-registered 503B outsourcing facility based in Houston, Texas. That classification matters. Section 503B of the Drug Quality and Security Act subjects these facilities to current Good Manufacturing Practice (cGMP) standards, mandatory FDA inspections, and stricter quality controls than traditional 503A compounding pharmacies. The FDA maintains a public list of registered 503B outsourcing facilities at fda.gov, and Help appears on that list.
What 503B Registration Actually Means for Patients
A 503B pharmacy can produce large batches of compounded drugs without patient-specific prescriptions, which improves lot-to-lot consistency. Quality control testing is required for sterility, potency, and endotoxins. That is a meaningful distinction from a small 503A shop. Patients ordering compounded injectables, including semaglutide or tirzepatide, benefit from this additional layer of manufacturing oversight.
503B status does not guarantee clinical appropriateness. A pharmacy fulfills prescriptions. It does not diagnose, adjust your dose based on side effects, or flag contraindications in real time. Patients who need hands-on clinical management, not just a compounded drug shipped to their door, may find the Help model insufficient on its own.
FDA Shortage Status and Legal Compounding
The FDA declared the semaglutide shortage resolved in March 2024 and the tirzepatide shortage resolved in late 2024. Under 503B regulations, compounding a drug that appears on the FDA's drug shortage list is permissible. Once a shortage is resolved, legal compounding of that active pharmaceutical ingredient becomes more restricted. Patients should confirm current shortage status at accessdata.fda.gov before ordering, because the legal field for compounded GLP-1s shifted significantly through 2024 and into 2025.
Help Pharmacy Compounded GLP-1: Clinical Context
Compounded semaglutide and tirzepatide are not FDA-approved drugs. They are compounded copies of Ozempic, Wegovy, Mounjaro, and Zepbound. The clinical trial data supporting weight loss and cardiometabolic benefit belongs to the branded, FDA-approved formulations.
The Evidence Behind GLP-1 Therapy
STEP-1 (N=1,961) showed semaglutide 2.4 mg subcutaneous weekly produced 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo. [1] The SELECT trial (N=17,604) showed the same semaglutide dose reduced major adverse cardiovascular events by 20% in overweight or obese adults without diabetes. [2] For tirzepatide, SURMOUNT-1 (N=2,539) showed up to 22.5% mean weight loss at 72 weeks with the 15 mg dose. [3]
These outcomes were observed with pharmaceutical-grade, FDA-approved products. Compounded versions may contain the same active pharmaceutical ingredient, but potency verification, excipient composition, and bioavailability are not independently validated to the same standard.
Help's GLP-1 Formulations
Help offers subcutaneous injectable semaglutide and tirzepatide in multi-dose vials, typically with B12 or L-carnitine added. Some formulations use sodium acetate buffering. The additions are not clinically meaningless. Some patients report better injection-site tolerability. However, no randomized controlled trial has compared these modified compounded formulations to branded Wegovy or Zepbound for efficacy or safety. Patients should weigh that gap when choosing.
Best Help Pharmacy Alternatives by Use Case
Not every patient has the same priority. The right alternative depends on whether you need clinical management, lower cost, a specific drug category, or a full-service telehealth experience.
Alternative 1: Ro Body (Best for GLP-1 with Full Telehealth Support)
Ro Body pairs compounded or brand-name GLP-1 therapy with licensed physicians who adjust dosing, manage side effects, and provide ongoing check-ins. The platform integrates pharmacy fulfillment with clinical care in a single subscription. For patients who want someone accountable for their treatment plan, not just a prescription pad, Ro offers a meaningful advantage over a pharmacy-only model.
Pricing runs approximately $99/month for the Ro Body membership on top of medication costs. Compounded semaglutide through Ro has been priced around $299/month for maintenance doses, though pricing changes frequently.
Ro is best suited for patients who are new to GLP-1 therapy, have comorbidities like hypertension or prediabetes, or who have previously struggled with nausea and need active titration support.
Alternative 2: Hallandale Health (Best for HRT and Hormone Compounding)
Hallandale Health is a licensed 503A pharmacy with a long track record in compounded hormone therapy, including estradiol, progesterone, testosterone cream, and DHEA. For women navigating perimenopause or menopause, Hallandale's breadth of HRT formulations and their collaboration with physician networks makes them a credible alternative to Help's hormone offerings.
The Menopause Society (formerly NAMS) 2023 position statement notes that compounded bioidentical hormones may be appropriate when FDA-approved formulations do not meet a patient's clinical needs, such as non-standard doses or delivery routes. [4] However, the same statement cautions that compounded preparations lack the safety and efficacy data of approved products.
Hallandale's pricing for compounded estradiol creams typically runs $40, $80 per tube. Progesterone capsules are similarly priced, often lower than Help's listed rates for equivalent products.
Alternative 3: Tailor Made Compounding (Best for Peptide Therapy)
Tailor Made Compounding is a 503A pharmacy in Georgetown, Kentucky, with an extensive peptide formulary. For patients seeking BPC-157, TB-500, CJC-1295, ipamorelin, or PT-141, Tailor Made has broader availability and established clinical relationships with functional medicine and sports medicine practitioners.
One important note: the FDA has restricted several peptides, including BPC-157 and TB-500, from bulk compounding. Patients should verify current availability and legal status through their prescribing physician before ordering any peptide from any pharmacy. The FDA's bulk drug substances list is updated at fda.gov.
For legal peptides, Tailor Made's quality reputation among functional medicine physicians is strong. Turnaround times for custom compounded peptide vials average 5 to 10 business days.
Alternative 4: Defy Medical (Best for TRT)
Defy Medical is a telehealth clinic, not a pharmacy, but it operates its own dispensing pharmacy in Tampa, Florida. For patients seeking testosterone replacement therapy, Defy offers physician-supervised protocols with lab monitoring, injection training, and dose adjustments. Their model covers testosterone cypionate, enanthate, and topical formulations, plus ancillaries like HCG, anastrozole, and clomiphene.
The American Urological Association 2018 guidelines (updated 2022) state that testosterone therapy is indicated for symptomatic hypogonadism confirmed by two morning total testosterone measurements below 300 ng/dL. [5] Defy's intake process includes baseline labs, which is a step that pharmacy-only models like Help cannot complete without a separate prescribing provider.
Defy's monthly TRT cost, including medication and physician oversight, runs approximately $150, $250 depending on protocol complexity.
Alternative 5: Strive Pharmacy (Best for Cost-Sensitive GLP-1 Patients)
Strive Pharmacy is a 503A compounding pharmacy that works with independent prescribers across the country. Their compounded semaglutide pricing has been among the lower end of the market, sometimes available below $150/month for lower doses. The trade-off is a more variable prescriber experience, since patients must source their own provider or use a third-party telehealth service.
For a cost-conscious patient with an existing obesity medicine physician who can write a compounded GLP-1 prescription, Strive can be a practical cost-reduction alternative to Help.
Help Pharmacy vs. Alternatives: Side-by-Side Comparison
| Feature | Help Pharmacy | Ro Body | Hallandale Health | Defy Medical | |---|---|---|---|---| | Facility type | 503B | Telehealth + pharmacy | 503A | Telehealth + dispensing | | GLP-1 compounding | Yes | Yes | Limited | No | | HRT compounding | Yes | Limited | Extensive | Yes | | Peptides | Yes | No | Limited | Limited | | TRT | Yes | No | Yes | Extensive | | In-house physician | No | Yes | No | Yes | | Approx. GLP-1 cost/mo | $150, $350 | $299+ | N/A | N/A | | FDA registration tier | 503B (stricter) | N/A | 503A | 503A |
How to Choose: A Clinical Decision Framework
Selecting the right pharmacy or telehealth platform depends on four variables: the drug category you need, whether you require active clinical management, your budget, and your tolerance for regulatory uncertainty around compounded drugs.
Step 1: Identify Your Primary Drug Category
GLP-1 therapy, hormone replacement, peptides, and testosterone replacement each have different regulatory environments and different quality standards across pharmacies. A pharmacy with a strong GLP-1 compounding record may have a thin peptide formulary. Match the pharmacy to the primary drug, not to brand recognition.
Step 2: Assess Your Clinical Complexity
Patients with BMI <27 seeking off-label GLP-1 use, patients with a history of medullary thyroid carcinoma or MEN2, and patients on multiple cardiometabolic drugs need physician oversight that a pharmacy-only model cannot provide. The same applies to TRT patients with polycythemia risk or fertility concerns. In those cases, a telehealth clinic (Ro, Defy, Hone Health) paired with a pharmacy is safer than a standalone pharmacy relationship.
Step 3: Verify Current Regulatory Status
Compound GLP-1 legality depends on FDA shortage status. Peptide availability depends on the 503A/503B bulk drug list. Both change without public fanfare. Check the FDA shortage database and the bulk drug substances list before committing to any pharmacy, including Help.
Step 4: Confirm Lab Monitoring Is in Place
The Endocrine Society's 2021 clinical practice guideline on obesity pharmacotherapy recommends monitoring glycated hemoglobin, fasting glucose, lipids, and renal function at baseline and at regular intervals during GLP-1 therapy. [6] A pharmacy cannot order labs. Ensure your prescribing provider has a monitoring plan, regardless of which pharmacy you use.
Help Pharmacy Reviews: What Patients and Clinicians Report
Patient-reported experiences with Help Pharmacy are broadly positive for shipping speed and product consistency. Several functional medicine physicians who work with Help note that the 503B manufacturing standards give them more confidence in potency than some 503A alternatives. Physician feedback also surfaces two consistent concerns.
First, multi-dose vials of compounded semaglutide require careful reconstitution and storage. Errors in dilution or refrigeration can alter effective dose. Patients without injection training background are more prone to dosing errors with multi-dose vials than with auto-injector pens like Wegovy.
Second, the addition of B12 to compounded semaglutide, a common Help formulation feature, has no randomized trial evidence supporting benefit. Some patients with methylation disorders or MTHFR variants may respond differently to supplemental B12. A prescribing physician should review the full formulation, not just the semaglutide dose, before a patient starts.
A Note on Third-Party Reviews
Online reviews of Help Pharmacy skew positive on shipping logistics and skew more mixed on customer service response times during high-demand periods. Independent verification of compounding pharmacy quality is limited for consumers. The most reliable signal remains FDA inspection records, which are available through the FDA warning letter database at fda.gov.
Specific Clinical Populations: Who Benefits Most from Each Alternative
Patients with Obesity and Type 2 Diabetes
This group benefits most from branded GLP-1 therapy or a telehealth platform with physician oversight. The American Diabetes Association's 2024 Standards of Care recommend GLP-1 receptor agonists as preferred agents for weight management in adults with type 2 diabetes who have cardiovascular disease or high cardiovascular risk. [7] For this population, the documented safety profile of Ozempic or Victoza is clinically preferable to a compounded alternative when insurance coverage is available.
If cost is the barrier, Help or Strive Pharmacy compounded semaglutide with a monitoring physician is a reasonable second option.
Women in Perimenopause or Menopause
Hallandale Health or a dedicated HRT telehealth platform (Midi Health, Gennev) will typically outperform Help for this use case. The breadth of estradiol delivery options, the clinical integration, and the provider familiarity with the Menopause Society guidelines give these platforms a practical edge.
Men with Hypogonadism
Defy Medical or Hone Health, both of which pair physician-supervised TRT with pharmacy dispensing, offer a more complete treatment model than Help for this population. The AUA guideline's requirement for confirmed low testosterone with two separate lab measurements underscores the need for physician involvement before any testosterone prescription is filled. [5]
Athletes and Functional Medicine Patients Seeking Peptides
Tailor Made Compounding has the deepest peptide formulary of any alternative listed here. Patients should work with a physician experienced in peptide dosing protocols, given the limited published clinical trial data supporting most peptide therapies outside of growth hormone secretagogues studied in small trials.
Cost Breakdown: Help Pharmacy vs. Alternatives
Monthly cost estimates for common use cases:
- Compounded semaglutide (maintenance dose ~1 mg/week): Help $199, $299, Strive $130, $175, Ro Body $299+
- Compounded tirzepatide (5 mg/week): Help $250, $350, varies by pharmacy and dose
- Compounded estradiol cream: Help $60, $100, Hallandale $40, $80
- Testosterone cypionate 200 mg/mL (10 mL vial): Help $50, $90, Defy Medical bundled into ~$200/month plan
- Compounded ipamorelin/CJC-1295: Help $120, $180, Tailor Made $100, $160
These figures are estimates based on publicly listed prices as of early 2025 and will shift with regulatory changes, shortage status, and compounding costs.
Frequently asked questions
›Is Help Pharmacy worth it?
›How much does Help Pharmacy cost?
›What does Help Pharmacy prescribe?
›Is Help Pharmacy legit?
›Can Help Pharmacy compound semaglutide legally?
›What is the best alternative to Help Pharmacy for weight loss?
›How does Help Pharmacy compare to Hallandale Health?
›Does Help Pharmacy require a prescription?
›What are the risks of compounded GLP-1 medications?
›Is compounded tirzepatide safe?
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. https://www.nejm.org/doi/10.1056/NEJMoa2307563
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/10.1056/NEJMoa2206038
- The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The Menopause Society. Menopause. 2023;30(6):573-590. https://www.menopause.org/docs/default-source/professional/2023-nonhormone-therapy-position-statement.pdf
- American Urological Association. Evaluation and Management of Testosterone Deficiency (2018, amended 2022). https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Endocrine Society. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(2):342-362 (reaffirmed 2021). https://pubmed.ncbi.nlm.nih.gov/25590212/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1